Inari Medical Current Ratio 2019-2024 | NARI
Inari Medical current ratio from 2019 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Inari Medical Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $0.25B | $0.14B | 1.80 |
| 2024-03-31 | $0.23B | $0.09B | 2.71 |
| 2023-12-31 | $0.24B | $0.08B | 3.09 |
| 2023-09-30 | $0.47B | $0.07B | 7.10 |
| 2023-06-30 | $0.45B | $0.06B | 7.63 |
| 2023-03-31 | $0.43B | $0.05B | 8.80 |
| 2022-12-31 | $0.42B | $0.06B | 7.53 |
| 2022-09-30 | $0.41B | $0.04B | 9.70 |
| 2022-06-30 | $0.41B | $0.04B | 10.04 |
| 2022-03-31 | $0.41B | $0.04B | 11.62 |
| 2021-12-31 | $0.25B | $0.04B | 5.77 |
| 2021-09-30 | $0.23B | $0.03B | 7.73 |
| 2021-06-30 | $0.23B | $0.03B | 7.23 |
| 2021-03-31 | $0.22B | $0.02B | 10.73 |
| 2020-12-31 | $0.21B | $0.01B | 14.86 |
| 2020-09-30 | $0.20B | $0.01B | 13.92 |
| 2020-06-30 | $0.22B | $0.01B | 20.16 |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.436B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.021B | 27.33 |
| Intuitive Surgical (ISRG) | United States | $172.269B | 97.54 |
| Alcon (ALC) | Switzerland | $47.692B | 33.57 |
| IQVIA Holdings (IQV) | United States | $41.794B | 23.68 |
| Edwards Lifesciences (EW) | United States | $41.042B | 26.31 |
| IDEXX Laboratories (IDXX) | United States | $39.200B | 47.16 |
| DexCom (DXCM) | United States | $27.734B | 39.55 |
| STERIS (STE) | Ireland | $22.376B | 26.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.049B | 0.00 |
| Waters (WAT) | United States | $21.250B | 31.68 |
| Hologic (HOLX) | United States | $18.538B | 20.15 |
| Sysmex ADR (SSMXY) | Japan | $12.254B | 38.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.502B | 12.89 |
| Teleflex (TFX) | United States | $11.121B | 17.29 |
| Globus Medical (GMED) | United States | $9.556B | 26.73 |
| Penumbra (PEN) | United States | $7.893B | 81.93 |
| Masimo (MASI) | United States | $7.481B | 40.06 |
| Glaukos (GKOS) | United States | $6.973B | 0.00 |
| TransMedics (TMDX) | United States | $4.510B | 193.13 |
| Integer Holdings (ITGR) | United States | $4.334B | 25.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.724B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.852B | 16.73 |
| Veracyte (VCYT) | United States | $2.613B | 162.00 |
| Elekta AB (EKTAY) | Sweden | $2.595B | 21.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.427B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.246B | 13.98 |
| RxSight (RXST) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.492B | 6.80 |
| Artivion (AORT) | United States | $1.086B | 99.69 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.037B | 18.50 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.723B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.683B | 17.24 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| IRadimed (IRMD) | United States | $0.639B | 34.53 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.595B | 0.00 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Paragon 28 (FNA) | United States | $0.478B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 10.26 |
| Treace Medical Concepts (TMCI) | United States | $0.327B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.320B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.289B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.260B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.231B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| NeuroPace (NPCE) | United States | $0.193B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.192B | 13.46 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| 908 Devices (MASS) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.109B | 16.15 |
| EDAP TMS S.A (EDAP) | France | $0.097B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.042B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.038B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.027B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |